AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology

Recruitingn/aAges 18 Years - anyFemaleZIWIG
💬

In plain words

What the trial is, and whether it could suit you

GynRAN is an international, multicentre, transversal, diagnostic and non-interventional study carried out in gynecology-obstetrics/gynecological oncology departments that aims to identify a diagnostic signature for gynecological pathologies by analyzing of coding and non-coding RNA contained in patients saliva. The study population consists of patients with clinically symptomatic females with one or more of the gynecological pathologies (endometriosis, adenomyosis, ovarian cysts, fibroids, ovarian/cervical/uterine cancer) and asymptomatic females. The patients concerned by the study will be managed without modification of the care pathway, nor modification of the therapeutic indications, nor modification of the diagnostic or follow-up examinations necessary according to the context, which are carried out according to the local recommendations.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1. Subject of legal age (according to local legislation) and at least 18 years old 2. Subject (and if applicable her legal representative) having dated and signed the informed consent form 3. Subject with a medical insurance policy 4. Subject presenting to the department: 1. With Symptoms (bleeding and/or pain and/or clinically observed symptom) of one or more of the following pathologies (suspected undergoing diagnostic surgery/biopsy or diagnosed and before any curative treatment of the pathology): * Endometriosis * Adenomyosis, * Ovarian cysts, * Fibroids, * Ovarian cancer, * Cervical cancer, * Uterine cancer. 2. Asymptomatic with pap smear positive for cervical dysplasia or cervical cancer and before any curative treatment. 3. Asymptomatic undergoing a pap smear for cervical cancer screening in a gynecological follow-up context. Exclusion Criteria: 1. Recent (\<1 month) or ongoing bacterial or viral infection 2. Known active oral or digestive mycosis 3. Evolving oral pathology, symptomatic or obvious 4. Known pregnancy 5. Known current non-gynecological pelvic pathology 6. Subject with a diagnosed breast cancer or cancer other than gynecological with the exception of basal cell carcinoma 7. Subject with a history of treated cancer within the last 5 years with the exception of basal cell carcinoma 8. Subject who has already received chemotherapy or radiotherapy or undergone complete or partial excision of the gynecological pathology of inclusion criterion 9. Subject with significant difficulties reading or writing her language 10. Subject unable to comply with study and/or follow-up procedures 11. Participation in an interventional study with investigational drug or in the exclusion period of an interventional study.
💊

What it tests

  • Saliva sample
📍

Where

13 sites
CHU d'Angers
Angers, France
Clinique Tivoli Ducos - IFEMENDO
Bordeaux, France
Institut Bergonié
Bordeaux, France
CHU Caen
Caen, France
CGFL
Dijon, France
CHU Lyon Sud
Lyon, France
American Hospital of Paris
Neuilly-sur-Seine, France
CHU de Rennes Site Hôpital Sud
Rennes, France

…and 5 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy